APA (7th ed.) Citation

Xie, W., Xiao, W., Chang, H., Xu, M., Hu, Y., Zhou, T., . . . Gao, Y. (2025). Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: Phase 3 multicentre randomised controlled trial. BMJ (Online), 389, e081557. https://doi.org/10.1136/bmj-2024-081557

Chicago Style (17th ed.) Citation

Xie, Wei-Hao, et al. "Four Cycles of Docetaxel Plus Cisplatin as Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy in Stage N2-3 Nasopharyngeal Carcinoma: Phase 3 Multicentre Randomised Controlled Trial." BMJ (Online) 389 (2025): e081557. https://doi.org/10.1136/bmj-2024-081557.

MLA (9th ed.) Citation

Xie, Wei-Hao, et al. "Four Cycles of Docetaxel Plus Cisplatin as Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy in Stage N2-3 Nasopharyngeal Carcinoma: Phase 3 Multicentre Randomised Controlled Trial." BMJ (Online), vol. 389, 2025, p. e081557, https://doi.org/10.1136/bmj-2024-081557.